Cervomed inc.CRVO.US Overview

US StockHealthcare

(No presentation for CRVO)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

CRVO Overall Performance

CRVO AI Analysis & Strategy

CRVO Recent Performance

-8.77%

Cervomed inc.

0.81%

Avg of Sector

-1.14%

S&P500

CRVO PowerScanner

CRVO Key Information

CRVO Valuation Metrics

CRVO Earnings Table

CRVO Profile

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.